Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Management and Monitoring of HBV Reactivation in Immunocompromised Patients in Turkey (REANT STUDY)

NCT07529171 is registered in ClinicalTrials.gov with Yaşar Bayındır, MD as lead sponsor.

NCT NCT07529171
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07529171 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Management and Monitoring of HBV Reactivation in Immunocompromised Patients in Turkey (REANT STUDY)
Lead sponsor
Yaşar Bayındır, MD
Phase
Observational
Overall status
Recruiting
Start date
March 9, 2026
Completion date
December 31, 2029
Enrollment
490 (estimated)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

hbv